Anondita Medicare Secures ₹29.2 Million Order From CMSS

Anondita Medicare Limited, a prominent Indian manufacturer of condoms and sexual wellness products, has officially secured a major domestic purchase order valued at ₹29.24 million (₹2,92,41,000) from the Central Medical Services Society (CMSS). The regulatory disclosure filed on June 16, 2026, confirms that the central procurement agency, operating under the Ministry of Health and Family Welfare, Government of India, has selected the enterprise to bolster public health supply chains. This milestone underscores the company's escalating footprint in both institutional public welfare sectors and global commercial spaces.

Technical Details of the CMSS Procurement Contract

According to the official intimation filed with the National Stock Exchange (NSE) pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, the project operates under specific purchase order guidelines.

• Contract ID & Directives: The transaction is registered under Purchase Order No: 10282600139/PDI/Domestic Fund-DF.

• Product Allocation: The contract mandates the comprehensive supply of Condoms SMO, designated specifically as "Ustad Nirodh-HLL".

• Financial Scale: The aggregate valuation of the domestic mandate reaches exactly ₹2,92,41,000/- (Rupees Two Crore Ninety-Two Lakh Forty-One Thousand Only).

The order follows rigorous evaluation parameters managed by the central agency, cementing Anondita Medicare's alignment with stringent statutory compliance models mandated by the SEBI Master Circular No. HO/49/14/14(7)2025CFD-POD2/I/3762/2026.

Market Dynamics and Institutional Strategy

The awarding of this tender highlights Anondita Medicare's dual-track growth model, which balances robust domestic healthcare mandates alongside targeted international expansion. Historically localized as a significant small-scale manufacturing presence in Northern India, the enterprise has aggressively leveraged automation-led capacity enhancements to serve larger governmental bodies.

This institutional development comes on the heels of the company's international breakthrough earlier this month, where it secured its first export purchase order valued at approximately ₹43.14 crore under the South African Government condom procurement framework. By servicing both national programs via the CMSS and overseas state initiatives, the company is stabilizing its revenue streams against localized market shifts and cyclical economic changes.

Official Sources Section

The corporate disclosure was officially finalized and verified via a standard exchange broadcast signed by Bhawna Bisht, Company Secretary and Compliance Officer of Anondita Medicare Limited. Regulatory copies have been structured to conform with paragraph commitments specified under the oversight of the Securities and Exchange Board of India (SEBI) and the National Stock Exchange of India (NSE).

Executive Commentary

"According to officials and the corporate structural layout submitted to the exchanges, all key deliverables, terms, and conditions governing the supply of the contract will align with the structural framework accepted by the Company during the standard tender finalization process."

The executive desk previously noted that ongoing domestic supply stability directly complements the group’s overarching initiative to position high-volume sexual wellness portfolios within international institutional markets.

Why It Matters

For retail and institutional investors, securing a direct contract with a Ministry of Health and Family Welfare enterprise validates the industrial reliability and quality standards of Anondita Medicare’s manufacturing facilities. Financially, it ensures immediate revenue visibility within the current fiscal quarter. For the wider consumer population, the distribution of regulated health commodities ensures sustained support for national family planning and health campaigns via high-quality, government-vetted contraceptives.

Key Facts at a Glance

• Awarding Body: Central Medical Services Society (CMSS), a central procurement unit under the Ministry of Health and Family Welfare.

• Exact Capital Value: ₹2,92,41,000 (Two Crore Ninety-Two Lakh Forty-One Thousand Rupees).

• Product Line: Supply of Condoms SMO (Ustad Nirodh-HLL).

• Regulatory Compliance: Processed strictly in adherence to SEBI LODR Regulations (2015) and SEBI Master Circulars of 2026.

FAQ Section

Q1: What is the primary purpose of the order received by Anondita Medicare?

A1: The order dictates the procurement and supply of specialized Condoms SMO (specifically the "Ustad Nirodh-HLL" brand variant) to support domestic family planning and public health mandates.

Q2: Who issued this purchase order?

A2: The order was officially designated and issued by the Central Medical Services Society (CMSS), an agency under the Ministry of Health and Family Welfare, Government of India.

Q3: How does this impact Anondita Medicare’s market position?

A3: It strengthens the firm's position as a reliable institutional manufacturer within India, building upon its recent international tender successes, such as its ₹43.14 crore export order to South Africa.

Q4: Under what corporate laws was this transaction disclosed?

A4: The transaction was disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Source: Corporate Intimation Filed by Anondita Medicare Limited to the NSE, Regulatory guidelines via the Securities and Exchange Board of India (SEBI)